Zobrazeno 1 - 10
of 160
pro vyhledávání: '"Intratumoral administration"'
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Immunotherapy using inflammatory cytokines, such as interleukin (IL)-2 and interferon (IFN)-α, has been clinically validated in treating various cancers. However, systemic immunocytokine-based therapies are limited by the short half-life of recombin
Externí odkaz:
https://doaj.org/article/d5a4ea936e984a15849d439b4ffa93bb
Autor:
Jeongrae Kim, Sunejeong Song, Minjun Gwak, Hanhee Cho, Wan Su Yun, Namcheol Hwang, Jinseong Kim, Jun Seo Lee, Dong-Hwee Kim, Hyuncheol Kim, Seong Ik Jeon, Tae-il Kim, Kwangmeyung Kim
Publikováno v:
Biomaterials Research, Vol 27, Iss 1, Pp 1-24 (2023)
Abstract Background Nano-sized drug delivery system has been widely studied as a potential technique to promote tumor-specific delivery of anticancer drugs due to its passive targeting property, but resulting in very restricted improvements in its sy
Externí odkaz:
https://doaj.org/article/5512d15118024b71af6bd9cd5155ada3
Publikováno v:
Gels, Vol 10, Iss 5, p 307 (2024)
Nanostructured lipid carriers (NLCs) have the potential to increase the bioavailability and reduce the side effects of docetaxel (DTX). However, only a small fraction of nanoparticles given intravenously can reach a solid tumor. In situ-forming gels
Externí odkaz:
https://doaj.org/article/70ecbc5deda34b0688dca78c7d426ab9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Magnus Lindskog, Anna Laurell, Anders Kjellman, Bohuslav Melichar, Pablo Maroto Rey, Henryk Zieliński, Felipe Villacampa, Pierre Bigot, Bajory Zoltan, Omi Parikh, David Vazquez Alba, Åsa Jellvert, Tibor Flaskó, Enrique Gallardo, Maria José Ribal Caparrós, Gunta Purkalne, Peter Suenaert, Alex Karlsson-Parra, Börje Ljungberg
Publikováno v:
European Urology Open Science, Vol 40, Iss , Pp 38-45 (2022)
Background: The prognosis of patients with synchronous metastatic renal cell carcinoma (mRCC) is poor. Whereas single-agent tyrosine kinase inhibition (TKI) is clearly insufficient, the effects can be enhanced by combinations with immune checkpoint i
Externí odkaz:
https://doaj.org/article/22606199b57147bda45ec3fa0f159cf7
Autor:
Mujibur Khan, Md. Mahmudul Hasan, Anne Barnett, Raziye Piranlioglu, Mohammad Rashid, Ahmet Alptekin, Ali Arbab
Publikováno v:
Cancer Nanotechnology, Vol 13, Iss 1, Pp 1-18 (2022)
Abstract Background There is growing potential for nanocarrier-based drug delivery in cancer. However, an incomplete understanding of nano–bio interactions and the challenges regarding processing and fabrication in scale-up engineering techniques,
Externí odkaz:
https://doaj.org/article/38941091c6e84c198be914a83b72db25
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Nanomaterials, Vol 13, Iss 15, p 2225 (2023)
Over the last 30 years, diverse types of nano-sized drug delivery systems (nanoDDSs) have been intensively explored for cancer therapy, exploiting their passive tumor targetability with an enhanced permeability and retention effect. However, their sy
Externí odkaz:
https://doaj.org/article/392b2c92b08f44cb858b559c6b0f3048
Publikováno v:
Gels, Vol 9, Iss 7, p 593 (2023)
The widespread push to invest in local cancer therapies comes from the need to overcome the limitations of systemic treatment options. In contrast to intravenous administration, local treatments using intratumoral or peritumoral injections are indepe
Externí odkaz:
https://doaj.org/article/b1a049c812134accaf4bf9a90bef02c3
Autor:
J. Fréderique de Graaf, Marco Huberts, Daphne Groeneveld, Stefan van Nieuwkoop, Casper H.J. van Eijck, Ron A.M. Fouchier, Bernadette G. van den Hoogen
Publikováno v:
Heliyon, Vol 8, Iss 7, Pp e09915- (2022)
Pancreatic ductal adenocarcinoma (PDAC) is characterized by a poor clinical prognosis and is usually a metastatic disease. In the last decades, oncolytic viro-immunotherapy has shown a promise as treatment strategy with encouraging results for a vari
Externí odkaz:
https://doaj.org/article/c1a135311b8244719f92aaf6e2b78799